PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB

• Hyuna Lee,
• Jihye Park,
• Hyerin Jang,
• Jungryul Kim

Affiliations

Hyuna Lee

1 Samsung Bioepis, Clinical development, Korea, Rep. of South

Jihye Park

1 Samsung Bioepis, Clinical development, Korea, Rep. of South

Hyerin Jang

1 Samsung Bioepis, Clinical development, Korea, Rep. of South

Jungryul Kim

2 Samsung Medical Center, Department of Clinical Pharmacology and Therapeutics, Seoul, Korea, Rep. of South